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Background—Mammograms, unlike magnetic resonance imaging (MRI), are relatively 
geographically accessible. Additional travel time is often required to access breast MRI. However, 
the amount of additional travel time and whether it varies based on sociodemographic or breast 
cancer risk factors is unknown.
Methods—We examine screening mammograms and MRIs between 2005 and 2012 in the Breast 
Cancer Surveillance Consortium (BCSC) by a) travel time to the closest and actual mammography 
facility used, and the difference between the two; b) woman's breast cancer risk factors and c) 
socio-demographic characteristics. We used logistic regression to examine the odds of traveling 
farther than the closest facility in relation to women's characteristics.
Results—Among 821,683 screening mammograms, 76.6% occurred at the closest facility 
compared to 51.9% of screening MRIs (N=3,687). The median differential travel time among 
women not using the closest facility for mammography was 14 minutes (IQR: 8-25) versus 20 
minutes (IQR 11-40) for breast MRI. Differential travel time for both imaging modalities did not 
vary notably by breast cancer risk factors, but was significantly longer for non-urban residents. For 
non-Hispanic black, compared to non-Hispanic white women, the adjusted odds of traveling 
farther than the closest facility were 9% lower for mammography (OR 0.91; 95% CI:0.87-0.95), 
but more than two times higher for MRI (OR 2.64; 95% CI:1.36-5.13).
Conclusions—Breast cancer risk factors were not related to excess travel time for screening 
MRI, but sociodemographic factors were, suggesting the possibility that geographic distribution of 
advanced imaging may exacerbated disparities for some vulnerable populations.
Introduction
Mammography has been shown to be readily available in most geographic areas of the U.S. 
given its decades of diffusion and population-based need.1,2Studies reporting the influence 
of travel time to the nearest mammography facility on mammography utilization have found 
no significant association3. However, advanced breast imaging modalities, such as breast 
magnetic resonance imaging (MRI), have more limited geographic accessibility, 2 and may 
be imposing travel burdens on women who seek breast MRI examinations.
Breast MRI use has increased in the U.S. over the past decade for all clinical indications, 
including screening, preoperative assessment, treatment monitoring, and surveillance.4 Since 
2007 when the American Cancer Society (ACS) released guidelines for use of breast MRI as 
an adjunct to screening mammography in women with a lifetime breast cancer risk of 
≥20%5, use has accelerated4. In the U.S., this risk is met by an estimated 880,000 women6. 
Breast MRI's clinical benefits, combined with more limited geographic accessibility 
compared to mammography, raises the concern that travel burden may be a barrier to use of 
MRI by women who may benefit. Proximity to, and utilization of MRI may be related to 
breast cancer risk and sociodemographic factors.
Geographic access is often estimated as travel time based on the closest facility to a patient's 
residence. For breast cancer screening, most studies have measured the nearest 
mammography facility to women's locations2,7-12, with few studies measuring locations of 
facilities actually used by women.13 Understanding the travel time difference between the 
closest facility and that actually used will help to quantify the additional travel burden 
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experienced by women seeking supplemental breast MRI screening, which will inform 
patterns of breast MRI use. For example, in a national sample, use of breast MRI was more 
common among women with breast cancer risk factors and less common among women 
from vulnerable populations.4 Travel time to breast MRI is greater than to mammography2 
but whether this affects patterns of use for subpopulations is unknown.
Our objective was to examine whether clinical and sociodemographic characteristics of 
women in a breast screening population are associated with traveling farther than the nearest 
breast imaging facility when using mammography and breast MRI. We hypothesized that 
breast cancer risk factors may be associated with greater differential travel time to MRI since 
women with higher risk may be more willing to travel further for advanced imaging and that 
vulnerable populations would have greater differential travel time due to fewer advanced 
imaging services being located in proximity.
Methods
Study Population and Data
The study population included data from consenting women ages 30 and above in the 
National Cancer Institute (NCI)-funded BCSC with at least one screening breast exam from 
2005-2012. The BCSC is comprised of population-based breast cancer screening registries 
in New Hampshire, New Mexico, North Carolina, San Francisco, Vermont, and Western 
Washington State.14 All participating sites within the BCSC have received institutional 
review board (IRB) approval for either active or passive consenting processes or a waiver of 
consent to enroll participants, link data, and perform analytic studies. All procedures are 
Health Insurance Portability and Accountability Act (HIPAA) compliant and all registries 
and the Statistical Coordinating Center (SCC) have received a Federal Certificate of 
Confidentiality and other protection for the identities of women, physicians, and facilities 
involved in this research.
Patient and Imaging Exam Characteristics
Information on women's breast cancer risk factors, breast screening history, and socio-
demographics was captured at each breast imaging exam. Women self-reported demographic 
and clinical information such as date of birth/age, race/ethnicity, educational attainment, 
residential address, breast screening history, family and personal history of breast cancer, 
and history of breast procedures. Breast density and breast screening history was also 
recorded by radiologists and/or radiology technologists. The BCSC data also includes a 
calculated BCSC 5-year breast cancer risk score15 based on the combination of the risk 
factor information collected. Rurality of residence for each women was based on the 4-
category Rural-Urban Commuting Area (RUCA) code corresponding to her ZIP code.16,17 
We randomly selected one exam per type (mammography and MRI) per woman when 
multiple mammography or MRI exams were found within the study period and only 
included exams classified as screening examinations. Exams were classified as screening 
using standard definitions developed by the BCSC18 .The BCSC data record the facility at 
which each exam was performed.
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Geocoded Data and Travel Time Measures
Addresses for women, for BCSC facilities visited by members of the study population, and 
for all Food and Drug Administration (FDA)-certified mammography facilities within the 
BCSC regions, were geocoded to street-level latitude and longitude point locations using 
ArcGIS version 10 (ESRI - Environmental System Research Institute, Redlands, CA). We 
created an Origin-Destination Matrix (O-D Matrix)19 by calculating the travel time for each 
woman to each breast imaging facility within her BCSC registry's catchment area, which 
allowed us to determine travel time to her closest facility, as well as travel time to the facility 
at which she had a breast imaging exam on record. The O-D Matrix was derived using 
ESRI's Origin-Destination Matrix tool in ArcGIS and its Streetmap North America road 
network dataset20. Travel times were calculated within a 180-minute travel time buffer from 
the woman's residential address. Women residing >180 minutes from either the closest or the 
facility actually used were excluded. Closest travel time was defined as the travel time in 
minutes from a woman's residence to the breast imaging facility with the least travel time 
from her residence. Actual travel time was defined as the travel time from a woman's 
residence to the facility at which she received a given breast exam. Differential travel time 
was defined as the difference between the closest and actual travel times. A differential 
travel time of zero indicates that the facility used for a given exam was the closest facility to 
a woman's residence. To account for small variations in street address for imaging facilities 
within a medical center campus, we considered a five minute or less differential travel time 
to represent use of the same/closest facility.
Statistical Analysis
We summarized the percent of exams occurring at the closest facility for all exams 
combined and by patient characteristics for both mammography and MRI. We calculated the 
median and interquartile range of differential travel time among women who did not use 
their closest facility for both mammography and MRI, overall and by patient characteristics. 
Additionally, we estimated cumulative distribution functions for actual travel time stratified 
by patient characteristics. Using multivariable logistic regression, we estimated likelihood of 
not using the closest facility in relation to clinical and sociodemographic characteristics: age, 
prior screening mammography, rurality, race/ethnicity, and educational attainment. In 
addition to adjusting for woman-level characteristics, we also adjusted for BCSC regional 
registry and facility characteristics: imaging and biopsy services offered, academic medical 
center, facility type (multispecialty, full diagnostic radiology, breast imaging only, non-
radiology), profit/not-for-profit. All statistical analyses were conducted in R 3.1.221.
Results
Overall, 825,370 breast screening exams were included in the study (821,683 
mammography; 3,687 breast MRI). (Table 1) The majority of women were: aged 50-69, 
non-Hispanic white, college graduates, urban residents, of average risk for breast cancer, 
screened within the past 30 months, not dense-breasted, and not having history of a breast 
procedure. (Table 1) Differences in the proportion of women receiving MRI compared to 
mammography were notable for race/ethnicity, education, rurality, and breast cancer risk. 
Specifically women of the following characteristics were represented much more in the MRI 
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group relative to mammography: non-Hispanic white, college graduate or post-graduate 
education, urban residence, high risk of breast cancer, breast cancer screening in the past 30 
months, dense breasts, positive family history of breast cancer, and prior breast biopsy. 
(Table 1) The median actual travel times for MRI exams and mammograms were 10 min. 
(IQR:5-20 min.) and 14 min. (IQR:6-32 min.), respectively. (Table 2) The greatest 
differences in actual travel times between MRI and mammography were seen by rural/urban 
category of residence.
Cumulative probability distributions of actual travel time showed the proportion of women 
(vertical axis) with actual travel time less than or equal to the times given on the horizontal 
axis. When stratified by women's clinical breast characteristics, notably longer travel times 
were seen between mammography and MRI, but almost no differences within exam type by 
the clinical breast factors. (Figure 1) When plotting the cumulative probability functions by 
sociodemographic characteristics, we again saw a consistently greater travel time for MRI 
compared to mammography. We also observed marked differences in actual travel time to 
mammography and MRI by sociodemographic characteristics. For example, within MRI 
exams, the distribution of women's actual travel times varied markedly by rural-urban 
category of residence. (Figure 2) Actual travel time to mammography was the same by 
educational attainment level, but differed for MRI, with higher educational attainment 
showing a greater proportion of women with shorter travel times compared to lower 
educational attainment. (Figure 2) For age and race/ethnicity, small differences in actual 
travel time distributions can be seen, but these are not marked, and are similar for both 
mammography and MRI. (Figure 2)
For women receiving mammography screening, almost one quarter (23.4%) did not use their 
closest facility; whereas for MRI, almost half did not t use their closest facility (48.1%). 
(Table 3) For both mammography and MRI, older women, ages 70 and above, had lower 
proportions not using their closest facility. Non-Hispanic black women and women residing 
in small towns or isolated rural areas had the highest proportion not using the closest facility 
for MRI (64.9% and 75.9%, respectively), but this was not the case for mammography. 
(Table 3) For both mammograms and MRIs, the proportion of women using the closest 
facility did not vary notably by breast cancer risk factors.
Among women who did not use their closest facility, median differential travel time was 14 
min. (IQR:8-25 min.) for mammography and was 20 min. (IQR:11-40 min.) for MRI (Table 
3). While overall, for almost all sociodemographic and breast characteristics, differential 
travel time to MRI was notably longer than to mammography, there was little variation in 
differential travel time across patient characteristics for most factors. (Table 3) The largest 
discrepancies in differential travel time between mammography and MRI were seen for 
women living in rural areas and those who had not been screened in the prior 30 months. 
The median differential travel time to mammography for women living in small towns or 
isolated rural areas was 23 min. (IQR:13-38 min.), but was much longer for MRI (median 41 
min., IQR:23-67 min.). For women not screened in the past 30 months, median differential 
travel time to mammography was 13 min. (IQR:8-23 min.) and was 24 min. (IQR:13-48 
min.) to MRI.
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The likelihood of not using the closest facility significantly higher for all other rural/urban 
categories compared to urban core. This was evident for both mammography and MRI, with 
a much more pronounced effect in MRI. (Table 4) For example, women living in small 
towns or isolated rural areas were over three times more likely to use a facility other than 
their closest compared to women living in urban areas (OR:3.31;95% CI 3.21-3.42, urban 
reference). For MRI, women living in small towns or isolated rural areas were more than 14 
times more likely than urban women to not use their closest facility (OR:14.06; 95% CI 
9.49-20.81, urban reference). (Table 4) The association between race and differential travel 
time varied by imaging exam type. Specifically, for mammography, non-Hispanic black 
women were less likely to use a facility other than the closest compared to non-Hispanic 
white women (OR: 0.91; 95% CI 0.87-0.95; white reference). However, for MRI, non-
Hispanic black women had over two times greater odds than non-Hispanic white women of 
not using the closest facility (OR:2.64;95% CI 1.36-5.13; white reference). (Table 4)
Discussion
This study is the first to examine differential travel time to mammography and breast MRI 
exams.As expected, we found longer actual travel times and greater differential travel times 
to breast MRI compared to mammography. Differential travel time for mammography and 
breast MRI did not vary notably according to breast cancer risk factors. However, 
sociodemographic factors – particularly rural residence, non-Hispanic black race/ethnicity, 
and lower educational attainment were associated with greater differential travel time for 
MRI.
This study augments prior work by: a) measuring travel time from women's residential 
locations to facilities actually used versus the closest; b) examining MRI in addition to 
mammography; c) including breast cancer risk factors, which may modify breast imaging 
needs and behaviors, and d) including individually-measured socio-demographic 
characteristics. This study provides novel evidence on potential travel burdens for breast 
MRI among subgroups of women participating in breast cancer screening, which is 
estimated to include approximately 67% of women age 40 and older in the U.S. 22
Travel time has been shown to be important to utilization of some breast cancer services, so 
our a priori hypothesis was that breast cancer risk factors might influence breast cancer 
screening with MRI. However, we did not find any risk factors or the quantitative breast 
cancer risk score to be significantly related to differential travel time to mammography or 
MRI. Thus, our findings do not support a role for risk in modifying travel behaviors for 
women undergoing breast cancer screening for either modality. Women may not know their 
individual breast cancer risk, so may not factor it into decision making.
There are several limitations in our study. First, we were limited to the BCSC screening 
population rather than the entire U.S. Given that we included over 800,000 women, who are 
largely representative of the breast cancer screening population23, we still have a population-
based sample that is reasonably generalizable, although we recognize that some subgroups 
did not have large numbers using MRI, and were geographically clustered. Second, we 
included only screening exams, as clinical recommendations, patient motivations, and 
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referral patterns can differ between screening and diagnostic indications, which are beyond 
the scope of this study. Third, we did not adjust for insurance in our multivariable models 
due to limited data availability. Fourth, we assumed that each woman had access to a vehicle 
and was not taking public transportation. This is a common limitation in travel time 
studies2,3,8-11,24-27. Finally, we do not have a validated measure of what constitutes an 
acceptable travel time for subgroups of women.
Our findings suggest that differential travel time may pose a burden for more rural women 
and black women, but not any more of a burden for women with breast cancer risk factors 
than without. The clinical implications of these findings point to a need to more closely 
examine equity in access to breast MRI for vulnerable populations. Further, attention should 
be given to ensuring that women at high risk for breast cancer are accessing breast MRI as 
needed.
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Figure 1. 
Cumulative probability of actual travel times for women (N=825,370) to breast imaging 
modalities in relation to breast cancer risk factors.
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Figure 2. 
Cumulative probability of actual travel times for women (N=825,370) to breast imaging 
modalities in relation to sociodemographic factors.
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Table 1
Number and proportion of breast imaging exams by women's characteristics included in the study population 
from 2005-2012 in the Breast Cancer Surveillance Consortium.
Mammogram (n=821,683) MRI (n=3,687)
Age (years) N (%)*
 <40 28,137 (3.4) 482 (13.1)
 40-49 222,061 (27.0) 1,125 (30.5)
 50-59 241,697 (29.4) 1,190 (32.3)
 60-69 178,486 (21.7) 675 (18.3)
 70-79 102,551 (12.5) 173 (4.7)
 80+ 48,751 (5.9) 42 (1.1)
Race/ethnicity
 Non-hispanic white 512,556 (71.3) 2,843 (82.1)
 Non-hispanic black 45,639 (6.4) 86 (2.5)
 Non-hispanic Asian 86,691 (12.1) 307 (8.9)
 Hispanic 56,708 (7.9) 121 (3.5)
 Other 16,945 (2.4) 107 (3.1)
Education
 < HS grad 51,684 (9.1) 49 (1.5)
 HS grad or GED 124,676 (22.0) 310 (9.3)
 Some College 139,179 (24.5) 596 (17.9)
 College grad/post grad 252,122 (44.4) 2,377 (71.3)
Rural/Urban by Zip Code
 Large Rural town 117,783 (14.4) 420 (11.4)
 Small town/Isolated rural 135,990 (16.6) 556 (15.1)
 Suburban 60,579 (7.4) 144 (3.9)
 Urban Core 506,426 (61.7) 2,562 (70.0)
BCSC 5 year risk score
 High Risk (>1.67) 231,074 (37.1) 827 (56.2)
 Average Risk (<1.67) 391,714 (62.9) 644 (43.8)
Breast screening history
 Screened in past 30 months 585,063 (78.0) 3,430 (95.5)
 Not screened in past 30 months 165,488 (22.0) 161 (4.5)
Family history
 Positive 124,700 (15.2) 1,869 (50.7)
 Negative 665,636 (81.0) 1,707 (46.3)
Breast density
 Almost entirely fatty 41,326 (9.5) 105 (3.7)
 Scattered fibroglandular 202,334 (46.4) 881 (30.7)
 Heterogeneously dense 159,493 (36.5) 1,334 (46.5)
 Extremely dense 33,247 (7.6) 551 (19.2)
History of breast procedure
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Mammogram (n=821,683) MRI (n=3,687)
 None 590923 (79.0) 782 (23.7)
 Biopsy only 112069 (15.0) 1743 (52.7)
 Aspiration only 15590 (2.1) 38 (1.1)
 Both biopsy and aspiration 29027 (3.9) 743 (22.5)
*
Missing values were as follows: Race/ethnicity: mammogram: 103,144 (12%), MRI: 223 (6%); Education: mammogram: 254,022 (31%), MRI: 
355 (9%); Rural/urban: mammogram: 905 (0.1%), MRI: 5 (0.1%); BCSC 5 year risk score: mammogram: 198,895 (24%), MRI: 2,216 (60%); 
Breast screening history: mammogram: 71,132 (9%), MRI: 96 (3%); Family history: mammogram: 31,347 (4%), MRI: 111 (3%); Breast density: 
mammogram: 385,283 (47%), MRI: 816 (22%); History of breast procedure: mammogram: 74,074 (9%), MRI: 381 (10%).
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Table 2
Travel time to screening breast imaging exams recorded in the Breast Cancer Surveillance Consortium from 
2005-2012 (N=825,370).
Mammography (N=821,683) MRI (N=3,687)
Closest Travel Time Actual Travel Time Closest Travel Time Actual Travel Time
Median time; IQR (min.) Median time; IQR (min.)
All exams 6 (3,13) 10 (5,20) 5 (2,13) 14 (6,32)
Age (years)
 <40 6 (3,13) 11 (6,23) 5 (2,21.5) 17 (5,55)
 40-49 7 (3,15) 11 (6,24) 6 (3,23) 18 (7,66)
 50-59 7 (3,16) 12 (6,24) 6 (3,21) 17 (8,52)
 60-69 7 (3,16) 11 (6,23) 7 (3,21) 17 (7.5,49)
 70-79 6 (3,14) 10 (5,20) 7 (4,14) 13 (7,45)
 80+ 5 (2,11) 8 (4,15) 5.5 (3,15.25) 7 (5,18.25)
Race
 Non-hispanic white 8 (4,17) 12 (6,24) 7 (3,22) 18 (7,55)
 Non-hispanic black 6 (3,14) 11 (6,26) 7.5 (3,17) 23.5 (11.25,57)
 Hispanic 4 (2,6) 9 (5,15) 4 (3,8) 12 (6,28.5)
 Non-hispanic Asian 5 (2,12) 9 (5,21) 5 (2,19) 13 (7,41)
 Non-hispanic Other 6 (3,17) 11 (5,25) 7 (2,24.5) 17 (8,68)
Education
 < HS grad 5 (2,16) 9 (4,22) 5 (3,24) 12 (5,41)
 HS grad or GED 8 (4,19) 12 (5,25) 13 (5,26) 28 (12,65)
 Some College 7 (3,17) 11 (5,25) 7 (4,24) 20 (9,57)
 College grad/post grad 6 (3,16) 11 (5,23) 6 (2,20) 16 (6,50)
Rural/Urban by Zip Code
 Large Rural town 9 (4,16) 13 (5,25) 12 (5,17) 27 (7,57.25)
 Small town/Isolated rural 17 (7,28) 22 (9,36) 25 (13,33) 53 (37,89)
 Suburban 19 (12,26) 24 (16,33) 19 (13,26.25) 28 (22,41)
 Urban Core 5 (2,9) 9 (5,15) 5 (2,10) 11 (6,25)
BCSC 5 year risk score
 High Risk (>1.67) 8 (4,16) 11 (6,23) 7 (3,22) 18 (7.5,52)
 Average Risk (<1.67) 7 (3,15) 11 (6,23) 6 (2,22) 16 (6,49)
Breast screening history
 Screened in past 30 months 7 (3,16) 11 (6,24) 6 (3,21) 17 (7,51)
 Not screened in past 30 months 6 (3,14) 10 (5,21) 7 (2,24) 18 (8,67)
Family history
 Positve 7 (3,16) 11 (6,23) 6 (3,21) 16 (6,49)
 Negative 7 (3,15) 11 (6,23) 6 (3,22) 17 (8,57)
Breast density
 Almost entirely fatty 7 (3,16) 11 (5,23) 10 (4,22) 22 (9,42)
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Mammography (N=821,683) MRI (N=3,687)
Closest Travel Time Actual Travel Time Closest Travel Time Actual Travel Time
Median time; IQR (min.) Median time; IQR (min.)
 Scattered fibroglandular 8 (4,16) 11 (6,24) 8 (3,23) 20 (8,57)
 Heterogeneously dense 8 (4,16) 12 (6,23) 7 (3,21) 17 (7,53.75)
 Extremely dense 7 (3,15) 11 (6,23) 6 (2,26) 18 (6,70.5)
History of breast procedure
 None 6 (3,15) 11 (5,22) 6 (2,21.75) 16.5 (6,47)
 Biopsy only 7 (4,16) 11 (6,23) 6 (3,22.5) 17 (7,63.5)
 Aspiration only 6 (3,14) 11 (6,23) 5 (4,11) 18.5 (8.25,31)
 Both biopsy and aspiration 9 (4,20) 12 (6,26) 8 (3.5,22) 18 (8,48)
J Am Coll Radiol. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Onega et al. Page 15
Table 3
Proportion of women not using their closest facility and for the subset not using the closes facility, differential 
travel time to screening breast imaging exams recorded in the Breast Cancer Surveillance Consortium from 
2005-2012 (N=825,370).
Mammography (N=821,683) MRI (N=3,687)
Not using closest* 
facility (%)
Differential travel time 
(min.); median (IQR) **
Not using closest* 
facility (%)
Differential travel time 
(min.); median (IQR) 
**
All exams 23.4 14 (8,25) 48.1 20 (11,40)
Age (years)
 <40 29.6 15 (9,25) 42.6 22 (13,38)
 40-49 25.8 14 (8,24) 50.1 20 (11,40)
 50-59 24.7 14 (8,25) 49.8 19 (11,39)
 60-69 22.7 14 (8,25) 49.1 20 (11,41)
 70-79 18.9 13 (7,25) 43.8 16 (10,45)
 80+ 14.9 12 (7,23) 15.4 8 (8,9)
Race
 Non-Hispanic white 22.0 15 (9,26) 47.5 22 (12,45)
 Non-Hispanic black 27.0 18 (10,31) 64.9 25 (14,43)
 Hispanic 32.5 9 (6,14) 46.9 13 (8,22)
 Non-Hispanic Asian 23.7 12 (7,22) 50.0 12 (6,23)
 Non-Hispanic Other 24.7 13 (8,22) 53.3 17 (7,27)
Education
 < HS grad 19.2 10 (7,20) 41.3 12 (8,46)
 HS grad or GED 19.8 15 (9,26) 51.2 35 (19,56)
 Some College 23.8 15 (9,25) 51.3 22 (11,45)
 College grad/post grad 24.8 14 (8,23) 46.4 17 (10,35)
Rural/Urban by ZIP Code
 Large Rural town 23.2 25 (13,35) 51.9 34 (23,58)
 Small town/Isolated rural 23.1 23 (13,38) 75.9 41 (23,67)
 Suburban 28.3 15 (9,24) 57.9 20 (18,30)
 Urban Core 22.9 11 (7,17) 39.5 14 (8,20)
BCSC 5 year risk score
 High Risk (>1.67) 21.1 16 (9,27) 49.1 20 (11,46)
 Average Risk (<1.67) 24.3 14 (8,25) 41.6 20 (11,43)
Breast screening history
 Screened in past 30 months 22.9 14 (8,25) 47.3 19 (11,39)
 Not screened in past 30 months 23.5 13 (8,23) 50.4 24 (13,48)
Family history
 Positive 22.5 15 (8,25) 45.6 20 (11,43)
 Negative 23.4 14 (8,25) 50.0 19 (10,40)
Breast density
 Almost entirely fatty 21.8 15 (8,25) 45.7 22 (15,46)
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Mammography (N=821,683) MRI (N=3,687)
Not using closest* 
facility (%)
Differential travel time 
(min.); median (IQR) **
Not using closest* 
facility (%)
Differential travel time 
(min.); median (IQR) 
**
 Scattered fibroglandular 22.6 16 (9,28) 46.7 24 (14,46)
 Heterogeneously dense 24.4 15 (8,26) 47.3 22 (12,43)
 Extremely dense 26.1 13 (7,22) 48.5 18 (10,38)
History of breast procedure
 None 23.1 13 (8,23) 46.5 17 (9,33)
 Biopsy only 23.6 15 (8,26) 49.6 19 (11,39)
 Aspiration only 27.3 15 (8,26) 58.8 15 (7,21)
 Both biopsy and aspiration 21.1 17 (10,27) 46.2 23 (13,46)
*Closest defined a s any facility within 5 minutes of geographical closest facility
**
Median and interquartile range (IQR) of differential travel time for subjects not using the c losest facility.
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Table 4
Likelihood (odds ratios and 95% confidence intervals) of not using the closest facility in relation to women's 
sociodemographic and clinical characteristics for screening breast imaging exams in the Breast Cancer 
Surveillance Consortium (2005-2012).
Mammograms MRI
Patient characteristic OR* (95% CI) OR** (95% CI)
n = 419,446 n= 2,973
Age (years)
 <40 1.00 (ref) 1.00 (ref)
 40-49 0.82 (0.77, 0.87) 1.39 (1.06, 1.84)
 50-59 0.79 (0.74, 0.84) 1.39 (1.05, 1.82)
 60-69 0.75 (0.70, 0.80) 1.24 (0.92, 1.68)
 70-79 0.61 (0.57, 0.66) 1.00 (0.65, 1.54)
 80+ 0.48 (0.45, 0.52) 0.24 (0.09, 0.69)
Screened in past 30 months
 No 1.00 (ref) 1.00 (ref)
 Yes 1.01 (0.98, 1.04) 0.80 (0.53, 1.21)
Rurality
 Urban Core 1.00 (ref) 1.00 (ref)
 Large Rural Town 1.78 (1.73, 1.84) 2.68 (1.79, 4.04)
 Small Town/Isolated Rural 3.31 (3.21, 3.42) 14.06 (9.49, 20.81)
 Sub-Urban 1.34 (1.29, 1.39) 5.27 (3.25, 8.54)
Race
 Non-Hispanic White 1.00 (ref) 1.00 (ref)
 Non-Hispanic Black 0.91 (0.87, 0.95) 2.64 (1.36, 5.13)
 Asian 1.09 (0.98, 1.22) 1.18 (0.89, 1.57)
 Hispanic 0.82 (0.77, 0.88) 1.26 (0.81, 1.96)
 Other 1.14 (1.07, 1.23) 1.20 (0.75, 1.92)
Education
 At most high school/GED 1.00 (ref) 1.00 (ref)
 At least some college 1.09 (1.07, 1.11) 1.22 (0.92, 1.61)
*Adjusted for all patient, facility characteristics, and BCSC site
**Adjusted for all patient characteristics and site
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